Printer Friendly

Articles from M2 Pharma (April 5, 2018)

1-23 out of 23 article(s)
Title Author Type Words
Boehringer Ingelheim and OSE Immunotherapeutics enter global immuno-oncology partnership. 192
Chiesi's Lamzede receives marketing authorisation from EMA. 243
CurveBeam passes CE Mark certification for LineUP and InReach orthopedic extremity CT systems. 255
First Patient Dosed in Synlogic Phase 1b/2a Trial of Synthetic Biotic Medicine for Treatment of Hyperammonemia. 265
First Therapy for Patients with MRD-Positive ALL Approved by FDA. 278
First US Patients Enrolled in Cerus Phase 3 Study of RBC System. 351
Ipsen names new executive vice president and chief business officer. 191
ITBMed closes up to USD67m in equity investment. 146
Ligand Agreement Makes Worldwide OmniAb Platform License Accessible to venBio Portfolio Companies. 259
Mallinckrodt adds new board members. 337
Marapharm Ventures concludes over-subscribed financing of units. 211
Mark J. Alles Assumes Responsibilities of Departing Celgene President and COO. 159
Nerlynx (neratinib) in Combination With Capecitabine or Paclitaxel Included in NCCN Guidelines as Treatment Option for Patients With Breast Cancer Brain Metastases. 183
Nordic Nanovector reports departure of CEO Luigi Costa. 144
Ortho Kinematics Names Erik Wagner Interim CEO. 182
Pfizer signs asset contribution agreement with Allogene Therapeutics. 106
PharmaCyte Clinical Trial Cells Shipped to Austrianova for Encapsulation. 183
St. David's HealthCare closes acquisition of The Austin Diagnostic Clinic. 213
The European Medicines Agency accepts cemiplimab marketing authorisation application for review. 172
The US FDA and the European Medicines Agency accept AstraZeneca's applications for moxetumomab pasudotox and Lynparza. 232
TherapeuticsMD Appoints Dr. Jane F. Barlow as Independent Director. 234
Twist Bioscience Secures Additional USD 50m Financing for Development of Digital Storage in DNA and Drug Discovery. 145
Windtree Therapeutics completes USD2.6m private placement. 140

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters